These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

51 related items for PubMed ID: 14035738

  • 1. Attempted bone-marrow autografts after large doses of nitrogen mustard.
    KRETCHMAR AL, ANDREWS GA, SITTERSON BW.
    N Engl J Med; 1963 Feb 21; 268():427-8. PubMed ID: 14035738
    [No Abstract] [Full Text] [Related]

  • 2. Attempt to treat malignant tumours with large doses of nitrogen mustard or x-rays and autologous bone marrow grafts.
    KOLAR V, MECHL Z, SAKALOVA J, SVABENIKOVA L.
    Folia Biol (Praha); 1963 Feb 21; 9():34-41. PubMed ID: 14034336
    [No Abstract] [Full Text] [Related]

  • 3. 6-[Bis(2-chloroethyl)amino]-6-deoxygalactopyranose hydrochloride (C6-galactose mustard), a new alkylating agent with reduced bone marrow toxicity.
    Schein PS, Green D, Dean SW, McPherson E.
    Cancer Res; 1987 Feb 01; 47(3):696-9. PubMed ID: 3802075
    [Abstract] [Full Text] [Related]

  • 4. Effect of cycloheximide on the bone marrow toxicity of nitrogen mustard.
    Weissberg JB, Herion JC, Walker RI, Palmer JG.
    Cancer Res; 1978 Jun 01; 38(6):1523-7. PubMed ID: 656182
    [Abstract] [Full Text] [Related]

  • 5. AUTOLOGOUS MARROW IN TREATMENT OF NITROGEN MUSTARD-INDUCED MARROW DEPRESSION.
    KAISER GA, HERTER FP, MARKOWITZ AM, EVANS S.
    Surgery; 1963 Aug 01; 54():329-32. PubMed ID: 14054722
    [No Abstract] [Full Text] [Related]

  • 6. Protective effects of an inhibitor of protein synthesis, cycloheximide, on bone marrow damage induced by cytosine arabinoside or nitrogen mustard.
    Ben-Ishay Z, Farber E.
    Lab Invest; 1975 Nov 01; 33(5):278-90. PubMed ID: 1186126
    [No Abstract] [Full Text] [Related]

  • 7. Proliferation and differentiation of transplanted bone marrow from mice treated with nitrogen mustard.
    Sharp JG, THOMAS DB, Briscoe CV.
    Exp Hematol; 1974 Nov 01; 2(1):1-8. PubMed ID: 4614984
    [No Abstract] [Full Text] [Related]

  • 8. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice.
    Cantrell JE, Green D, Schein PS.
    Cancer Res; 1986 May 01; 46(5):2340-3. PubMed ID: 2938728
    [Abstract] [Full Text] [Related]

  • 9. A quantitative study of muramidase distribution in normal and nitrogen mustard-treated rats.
    Lippman ME, Finch SC.
    Yale J Biol Med; 1972 Oct 01; 45(5):463-70. PubMed ID: 4635684
    [No Abstract] [Full Text] [Related]

  • 10. Ethanol mustard cytotoxicity in vitro toward murine leukemia and bone marrow progenitor cells.
    Naujokaitis SA, Fisher JM, Rabinovitz M.
    Res Commun Chem Pathol Pharmacol; 1981 Aug 01; 33(2):305-18. PubMed ID: 7302378
    [Abstract] [Full Text] [Related]

  • 11. Influence of WR2721 on DNA cross-linking by nitrogen mustard in normal mouse bone marrow and leukemia cells in vivo.
    DeNeve WJ, Everett CK, Suminski JE, Valeriote FA.
    Cancer Res; 1988 Nov 01; 48(21):6002-5. PubMed ID: 2844397
    [Abstract] [Full Text] [Related]

  • 12. Neuroblastoma metastases; diagnosis by bone marrow aspiration, with note on therapy with radioactive phosphorus and nitrogen mustard.
    LUHBY AL, DIAMOND LK.
    Proc Am Fed Clin Res; 1947 Nov 01; 3():52. PubMed ID: 18909327
    [No Abstract] [Full Text] [Related]

  • 13. Comparative effects of cyclophosphamide, nitrogen mustard, and total-body irradiation on survival and on white blood cells in rats.
    Host H.
    Radiat Res; 1966 Apr 01; 27(4):638-51. PubMed ID: 5934825
    [No Abstract] [Full Text] [Related]

  • 14. In vitro evaluation of hematopoiesis in mice treated with busulphan or nitrogen mustard.
    Anderson RW, Matthews KI, Crouse DA, Sharp JG.
    Biomed Pharmacother; 1982 Apr 01; 36(3):149-52. PubMed ID: 7150708
    [Abstract] [Full Text] [Related]

  • 15. [REGIONAL CHEMOTHERAPY OF MALIGNANT TUMORS. II. TREATMENT WITH MASSIVE DOSES OF NITROGEN MUSTARD WITH TEMPORARY COMPRESSION OF THE ABDOMINAL AORTA AND ITS COLLATERAL ARTERIES].
    OETTGEN HF, CLIFFORD P, BEECHER JL, GILLMORE JH.
    Klin Wochenschr; 1964 Mar 01; 42():218-24. PubMed ID: 14169591
    [No Abstract] [Full Text] [Related]

  • 16. Pathogenesis of the generalized Shwartzman reaction. Evaluation of platelets as a mediator of the suppressive effect of a nitrogen mustard.
    Smith SP, Nuckolls JW, Horn RC, Collins RD.
    Arch Pathol; 1968 May 01; 85(5):459-62. PubMed ID: 5650782
    [No Abstract] [Full Text] [Related]

  • 17. Cain's quinolinium (NSC 176319): protection of murine L1210 leukemia cells and bone marrow progenitor cells against mechlorethamine cytotoxicity and its application to combination chemotherapy.
    Naujokaitis SA.
    Res Commun Chem Pathol Pharmacol; 1981 Oct 01; 34(1):97-104. PubMed ID: 7313308
    [Abstract] [Full Text] [Related]

  • 18. Treatment of malignant tumours with high doses of nitrogen mustard (TS 160) and-or high doses of ionizing radiation under the protection of autologous bone marrow (evaluation after a period of 7 years).
    Kolár V, Kadlecová D.
    Neoplasma; 1970 Oct 01; 17(5):535-40. PubMed ID: 4992014
    [No Abstract] [Full Text] [Related]

  • 19. Protection of thoracic bone marrow by external hypothermia during administration of nitrogen mustard in dogs.
    Silberman R, Hofmeyer JJ.
    Ann Surg; 1966 Jan 01; 163(1):60-6. PubMed ID: 5904910
    [No Abstract] [Full Text] [Related]

  • 20. Long-term culture of autologous transplanted bone marrow for acute myeloid leukaemia: evidence for an in vitro haemopoietic defect and lack of correlation with the speed of engraftment.
    Straetmans N, Ma DD, Herman P, Zenebergh A, Chang A, Deneys V, De Bruyère M, Ferrant A.
    Bone Marrow Transplant; 1995 Mar 01; 15(3):421-8. PubMed ID: 7599567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.